Model
Edge
Amylyx Pharmaceuticals Inc.
0001971421
Filing Type
4
Filing Date
6/8/2025
Updated
6/9/25, 2:06 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership